[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EE200200528A - 2-fenüülpüran-4-ooni derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline kompositsioon ning ühendi ja kompositsiooni raviotstarbeline kasutamine - Google Patents

2-fenüülpüran-4-ooni derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline kompositsioon ning ühendi ja kompositsiooni raviotstarbeline kasutamine

Info

Publication number
EE200200528A
EE200200528A EEP200200528A EEP200200528A EE200200528A EE 200200528 A EE200200528 A EE 200200528A EE P200200528 A EEP200200528 A EE P200200528A EE P200200528 A EEP200200528 A EE P200200528A EE 200200528 A EE200200528 A EE 200200528A
Authority
EE
Estonia
Prior art keywords
phenylpyran
derivative
compound
preparation
therapeutic use
Prior art date
Application number
EEP200200528A
Other languages
English (en)
Inventor
Isabel Crespo Crespo Maria
Miguel Jimenez Mayorga Juan
Lluis Matallana Julia Josep
Feixas Gras Joan
Original Assignee
Almirall Prodesfarma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma Ag filed Critical Almirall Prodesfarma Ag
Publication of EE200200528A publication Critical patent/EE200200528A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
EEP200200528A 2000-03-16 2001-03-16 2-fenüülpüran-4-ooni derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline kompositsioon ning ühendi ja kompositsiooni raviotstarbeline kasutamine EE200200528A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000637 2000-03-16
PCT/EP2001/003042 WO2001068633A1 (en) 2000-03-16 2001-03-16 2-phenylpyran-4-one derivatives

Publications (1)

Publication Number Publication Date
EE200200528A true EE200200528A (et) 2004-04-15

Family

ID=8492732

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200528A EE200200528A (et) 2000-03-16 2001-03-16 2-fenüülpüran-4-ooni derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline kompositsioon ning ühendi ja kompositsiooni raviotstarbeline kasutamine

Country Status (27)

Country Link
US (1) US7354936B2 (et)
EP (1) EP1263751B1 (et)
JP (1) JP2003527389A (et)
KR (1) KR20030005221A (et)
CN (1) CN1429221A (et)
AR (1) AR030410A1 (et)
AT (1) ATE269316T1 (et)
AU (1) AU2001254692A1 (et)
BG (1) BG107101A (et)
BR (1) BR0109252A (et)
CA (1) CA2403149A1 (et)
CZ (1) CZ20023058A3 (et)
DE (1) DE60103859T2 (et)
EE (1) EE200200528A (et)
ES (1) ES2223830T3 (et)
HK (1) HK1048117A1 (et)
HU (1) HUP0301696A2 (et)
IL (1) IL151598A0 (et)
MX (1) MXPA02009016A (et)
NO (1) NO20024393L (et)
NZ (1) NZ521187A (et)
PE (1) PE20011333A1 (et)
PL (1) PL358062A1 (et)
RU (1) RU2002127728A (et)
SK (1) SK12832002A3 (et)
WO (1) WO2001068633A1 (et)
ZA (1) ZA200207184B (et)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465509B2 (en) 2000-06-30 2002-10-15 Merck Frosst Canada & Co. Pyrones as inhibitors of cyclooxygenase-2
ES2213485B1 (es) * 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
CN102731456B (zh) * 2011-04-01 2014-07-09 华中科技大学 一种抗肿瘤化合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH524613A (de) 1969-12-31 1972-06-30 Ciba Geigy Ag Verfahren zur Herstellung von neuen Imidazolderivaten
US3901908A (en) * 1970-12-28 1975-08-26 Ciba Geigy Corp 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles
US4304728A (en) * 1979-04-05 1981-12-08 Lilly Industries Limited 6-Substituted pyranone compounds and their use as pharmaceuticals
IL59748A (en) 1979-04-05 1983-11-30 Lilly Industries Ltd 5-substituted pyranone derivatives,their production and pharmaceutical compositions containing them
US6048850A (en) * 1992-09-22 2000-04-11 Young; Donald A. Method of inhibiting prostaglandin synthesis in a human host
CZ134396A3 (en) * 1993-11-19 1996-08-14 Parke Davis & Co Pyrone derivatives as protease inhibitors and antiviral agents
US5521213A (en) 1994-08-29 1996-05-28 Merck Frosst Canada, Inc. Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
US5541204A (en) 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
KR19980703559A (ko) 1995-04-04 1998-11-05 그레이엄브레레톤 이미다조［1,2-ａ］피리딘 유도체
AU738595B2 (en) 1997-11-19 2001-09-20 Kowa Co., Ltd. Novel pyridazine derivatives and medicines containing the same as effective ingredients
TW587079B (en) * 1998-09-25 2004-05-11 Almirall Prodesfarma Ag 2-phenylpyran-4-one derivatives

Also Published As

Publication number Publication date
NZ521187A (en) 2004-03-26
MXPA02009016A (es) 2004-10-15
NO20024393L (no) 2002-11-13
JP2003527389A (ja) 2003-09-16
DE60103859T2 (de) 2005-07-21
HK1048117A1 (zh) 2003-03-21
ATE269316T1 (de) 2004-07-15
WO2001068633A1 (en) 2001-09-20
BR0109252A (pt) 2002-12-24
EP1263751A1 (en) 2002-12-11
CN1429221A (zh) 2003-07-09
PL358062A1 (en) 2004-08-09
DE60103859D1 (de) 2004-07-22
SK12832002A3 (sk) 2003-11-04
ZA200207184B (en) 2003-12-08
BG107101A (bg) 2003-07-31
US20030232880A1 (en) 2003-12-18
RU2002127728A (ru) 2004-03-20
CZ20023058A3 (cs) 2004-01-14
US7354936B2 (en) 2008-04-08
ES2223830T3 (es) 2005-03-01
IL151598A0 (en) 2003-04-10
CA2403149A1 (en) 2001-09-20
KR20030005221A (ko) 2003-01-17
AU2001254692A1 (en) 2001-09-24
PE20011333A1 (es) 2002-01-16
AR030410A1 (es) 2003-08-20
EP1263751B1 (en) 2004-06-16
NO20024393D0 (no) 2002-09-13
HUP0301696A2 (hu) 2003-09-29

Similar Documents

Publication Publication Date Title
EE200100318A (et) Kinoliini derivaat, selle ühendi kasutamine ravimina, seda sisaldav farmatseutiline kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
EE200200046A (et) 8-fenüül-6,9-dihüdro-[1,2,4]triasolo[3,4-i]puriin-5-ooni derivaat, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon
PL396568A1 (pl) Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny
NO20006630L (no) Farmasöytisk sammensetning for behandlingen av diabetes
EE03613B1 (et) Omeprasooli naatriumisool,selle valmistamise protsess,seda sisaldav ravimkoostis ja selle kasutamine seedetrakti häirete ravimiseks
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
EE200300587A (et) Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE05286B1 (et) Perindopriili tert-butlamiinsoola kristalliline kamma-vorm, protsess selle valmistamiseks ning seda sisaldavad farmatseutilised kompositsioonid
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
EE05268B1 (et) Perindopriili tert-butlamiinsoola kristalliline alfa-vorm, selle valmistamisprotsess ja seda sisaldavad farmatseutilised kompositsioonid
EE200000482A (et) Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
EE200000483A (et) Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks
EE200200399A (et) Pürroolirea ühend, selle valmistamine ja kasutamine lipiidi- ja kolesteroolitaset alandava ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
EE04739B1 (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ning vaheühend ja selle valmistamismeetod
EE200200655A (et) 5-kloro-3-(4-metaansulfonüülfenüül)-6'-metüül[2,3']bipüridinüüli polümorfne vorm, selle valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
EE200300488A (et) Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
NO326689B1 (no) Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
EE200000767A (et) Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
EE200200199A (et) N-guanidinoalküülamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
EE200100662A (et) Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine
EE200300398A (et) Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon